PKM and neoplasm: Moreover, SIRT5 inhibition had no impact in A549 cells where wild-type PKM2 was replaced with the tumor-suppressing succinylation mimetic mutant K489E, bearing a negatively charged glutamate in place of the lysine residue targeted by SIRT5 [80].